Hospital
Southern Monterey County Memorial Hospital
Southern Monterey County Memorial Hospital was paid $16.39M by Medicaid between Jan 2018 and Nov 2024, across 224 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 27% of everything it billed.
33Billing provider infoSOUTHERN MONTEREY COUNTY MEMORIAL HOSPITAL
KING CITY, CA 93930
KING CITY, CA 93930
33aNPI1245420660assigned 08/01/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.39M
24GClaims556,835
24DCodes billed224
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#138 of 410
Median peer was paid$6.90M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 66,534 | $1.76M | |
| 2019 | 63,621 | $1.68M | |
| 2020 | 60,993 | $1.71M | |
| 2021 | 77,481 | $2.24M | |
| 2022 | 89,099 | $2.81M | |
| 2023 | 99,177 | $3.05M | |
| 2024incomplete | 99,930 | $3.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 27% | 59,177 | 54,082 | $4.36M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.8% | 25,902 | 7,867 | $1.12M |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3.9% | 906 | 816 | $632K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 2,177 | 2,046 | $612K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.2% | 11,243 | 4,028 | $519K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 10,485 | 10,018 | $507K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.9% | 4,401 | 2,640 | $478K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 2,157 | 1,951 | $476K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.8% | 3,247 | 3,223 | $458K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 4,192 | 3,977 | $359K |
| 80053 | Comprehensive metabolic panel | 2.0% | 31,209 | 29,470 | $323K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 35,318 | 32,805 | $268K |
212 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 6,663 | $244K |
| 80061 | Lipid panel | 1.5% | 17,310 | $238K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 13,601 | $232K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.3% | 2,104 | $212K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.3% | 8,316 | $211K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.3% | 2,733 | $206K |
| 99243 | 1.2% | 2,682 | $200K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.2% | 1,770 | $199K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 17,090 | $168K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.0% | 8,098 | $166K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 280 | $163K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,356 | $163K |
| 76830 | Ultrasound, transvaginal | <1% | 1,768 | $153K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,712 | $148K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,555 | $142K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,468 | $137K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,563 | $137K |
| 97014 | <1% | 7,523 | $133K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,286 | $133K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,174 | $129K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,131 | $127K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,820 | $111K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 658 | $91K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,442 | $77K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 49,685 | $77K |
| 76801 | <1% | 1,023 | $77K | |
| 86480 | <1% | 1,498 | $75K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,660 | $75K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,965 | $71K |
| 87088 | <1% | 8,307 | $65K | |
| Z7502 | <1% | 1,774 | $65K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 935 | $57K |
| 84439 | <1% | 6,298 | $57K | |
| 76770 | <1% | 551 | $54K | |
| 72141 | <1% | 85 | $53K | |
| 73562 | <1% | 1,724 | $53K | |
| 86703 | <1% | 3,352 | $47K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 624 | $46K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,815 | $44K |
| 97799 | <1% | 1,233 | $44K | |
| 81001 | <1% | 14,184 | $44K | |
| 73630 | <1% | 1,208 | $41K | |
| 83690 | <1% | 6,453 | $41K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,911 | $39K |
| 86403 | <1% | 3,075 | $37K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 5,753 | $36K |
| 72100 | <1% | 898 | $36K | |
| 87400 | <1% | 6,531 | $36K | |
| 73610 | <1% | 1,000 | $36K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,972 | $35K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 431 | $33K |
| 84484 | <1% | 3,659 | $33K | |
| 73030 | <1% | 827 | $29K | |
| 83013 | <1% | 468 | $29K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,241 | $28K |
| 87186 | <1% | 2,710 | $28K | |
| 82043 | <1% | 4,737 | $27K | |
| 83655 | <1% | 5,796 | $25K | |
| 82951 | <1% | 882 | $25K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,518 | $24K |
| 80076 | <1% | 2,867 | $23K | |
| 87081 | <1% | 3,122 | $23K | |
| 64483 | <1% | 1,121 | $22K | |
| 73221 | <1% | 43 | $22K | |
| 83880 | <1% | 1,062 | $21K | |
| 82962 | <1% | 4,582 | $20K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,677 | $20K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 101 | $20K |
| 87040 | <1% | 1,747 | $18K | |
| 83735 | <1% | 2,880 | $18K | |
| 85027 | <1% | 2,682 | $17K | |
| 86140 | <1% | 3,313 | $17K | |
| 92523 | <1% | 82 | $16K | |
| 87420 | <1% | 1,044 | $15K | |
| 93000 | <1% | 281 | $14K | |
| 72072 | <1% | 288 | $14K | |
| 86592 | <1% | 3,419 | $14K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,006 | $14K |
| 86803 | <1% | 1,713 | $13K | |
| 83605 | <1% | 1,485 | $13K | |
| 74018 | <1% | 486 | $12K | |
| 76642 | <1% | 150 | $11K | |
| 72083 | <1% | 147 | $11K | |
| 85610 | <1% | 2,565 | $10K | |
| 94664 | <1% | 410 | $10K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 1,746 | $10K |
| 86787 | <1% | 1,006 | $9K | |
| 76536 | <1% | 116 | $9K | |
| 73130 | <1% | 247 | $9K | |
| 86850 | <1% | 906 | $9K | |
| 86762 | <1% | 613 | $9K | |
| 72040 | <1% | 225 | $9K | |
| 85651 | <1% | 2,059 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,071 | $8K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 98 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 31 | $7K |
| 82150 | <1% | 1,034 | $7K | |
| 80055 | <1% | 122 | $7K | |
| 93971 | <1% | 48 | $7K | |
| 84702 | <1% | 482 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,257 | $7K |
| 81025 | <1% | 1,150 | $7K | |
| 73560 | <1% | 269 | $6K | |
| 84703 | <1% | 874 | $6K | |
| 83550 | <1% | 800 | $6K | |
| Z7610 | <1% | 981 | $6K | |
| 82728 | <1% | 954 | $6K | |
| 73110 | <1% | 167 | $6K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,562 | $5K |
| 82105 | <1% | 288 | $5K | |
| 86901 | <1% | 1,681 | $5K | |
| 86900 | <1% | 1,636 | $5K | |
| 85730 | <1% | 884 | $5K | |
| 84442 | <1% | 323 | $5K | |
| 82570 | <1% | 891 | $4K | |
| 82248 | <1% | 869 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,189 | $4K |
| 97116 | <1% | 284 | $4K | |
| 76641 | <1% | 47 | $4K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 148 | $4K |
| 99152 | <1% | 147 | $4K | |
| 97165 | <1% | 42 | $4K | |
| 59020 | <1% | 55 | $4K | |
| 73080 | <1% | 108 | $4K | |
| 72110 | <1% | 63 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 563 | $4K |
| 85007 | <1% | 761 | $4K | |
| 80074 | <1% | 171 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,184 | $3K |
| 77065 | Tomosynthesis, mammo | <1% | 24 | $3K |
| 86038 | <1% | 532 | $3K | |
| 83540 | <1% | 999 | $3K | |
| 85379 | <1% | 316 | $3K | |
| 73140 | <1% | 116 | $3K | |
| 77080 | <1% | 60 | $3K | |
| 87077 | <1% | 374 | $2K | |
| 84100 | <1% | 527 | $2K | |
| 82550 | <1% | 375 | $2K | |
| 62321 | <1% | 13 | $2K | |
| 84550 | <1% | 451 | $2K | |
| 80069 | <1% | 233 | $2K | |
| 73502 | <1% | 55 | $2K | |
| 84479 | <1% | 321 | $2K | |
| 86430 | <1% | 334 | $2K | |
| 84153 | <1% | 112 | $2K | |
| 84460 | <1% | 259 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 418 | $2K |
| 72114 | <1% | 15 | $1K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 155 | $1K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 13 | $1K |
| 82274 | <1% | 94 | $1K | |
| 90715 | <1% | 37 | $1K | |
| 93308 | <1% | 12 | $1K | |
| 81000 | <1% | 263 | $1K | |
| 81003 | <1% | 449 | $1K | |
| 96379 | <1% | 4,518 | $958.84 | |
| 86735 | <1% | 71 | $900.45 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 117 | $794.73 |
| 76970 | <1% | 14 | $717.72 | |
| 74019 | <1% | 24 | $694.83 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $655.05 |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $599.76 |
| 82947 | <1% | 129 | $586.28 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 294 | $548.93 |
| 97016 | <1% | 240 | $547.73 | |
| 76882 | <1% | 35 | $539.08 | |
| 73020 | <1% | 24 | $474.05 | |
| 83525 | <1% | 111 | $461.71 | |
| 62320 | <1% | 15 | $428.40 | |
| 73590 | <1% | 14 | $428.22 | |
| 84436 | <1% | 57 | $414.10 | |
| 73620 | <1% | 12 | $411.40 | |
| 87045 | <1% | 37 | $411.25 | |
| 64484 | <1% | 64 | $408.09 | |
| 76000 | <1% | 14 | $391.04 | |
| 84156 | <1% | 120 | $380.38 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 50 | $347.52 |
| 82247 | <1% | 55 | $283.68 | |
| 80051 | <1% | 34 | $261.02 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 172 | $252.20 |
| 81015 | <1% | 74 | $235.98 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 28 | $231.65 |
| 83516 | <1% | 25 | $213.85 | |
| 87147 | <1% | 13 | $186.03 | |
| 82950 | <1% | 28 | $175.10 | |
| 87210 | <1% | 26 | $156.48 | |
| 87205 | <1% | 38 | $155.86 | |
| 87070 | <1% | 13 | $154.96 | |
| 0450 | Emergency room services | <1% | 12 | $153.34 |
| A4217 | Sterile water/saline, 500 ml | <1% | 25 | $150.15 |
| 85018 | <1% | 65 | $142.20 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 42 | $136.52 |
| 83001 | <1% | 12 | $135.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,518 | $132.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 32 | $130.77 |
| 87427 | <1% | 13 | $128.44 | |
| 84146 | <1% | 12 | $120.00 | |
| 83014 | <1% | 14 | $117.36 | |
| 82553 | <1% | 12 | $110.35 | |
| 85045 | <1% | 28 | $102.68 | |
| 85014 | <1% | 47 | $101.91 | |
| 87177 | <1% | 14 | $101.83 | |
| 84403 | <1% | 12 | $81.12 | |
| 87340 | <1% | 28 | $58.50 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 13 | $50.22 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 27 | $43.80 |
| J2704 | Injection, propofol, 10 mg | <1% | 28 | $39.78 |
| 87046 | <1% | 13 | $37.96 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 36 | $20.61 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 16 | $4.83 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 26 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBECK, WALTER (CEO)
| Provider | Location | Paid |
|---|---|---|
| Southern Monterey County Memorial Hospital | King City, CA | $30.29M |
| Southern Monterey County Memorial Hospital | Greenfield, CA | $17.20M |
| Southern Monterey County Memorial Hospital | King City, CA | $2.95M |
| Southern Monterey County Memorial Hospital | King City, CA | $39K |
| Southern Monterey County Memorial Hospital | King City, CA | $36K |
| Southern Monterey County Memorial Hospital | Greenfield, CA | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.